Cosunter Pharmaceutical is a national hi-tech company focusing on the R&D and manufature of anti-HBV (hepatitis B virus) drugs. Founded in June 2001, it has now developed into a leading modern drug company with annual output value of over RMB 100 million yuan and tax paid of several dozens of million yuan. The company mainly produces crude drug and solid preparation, with forms of tablet, capsule, granule, medicinal tea etc. All production lines of the company passed the revised GMP certification in August 2014.
On April 22, 2015, Cosunter Pharmaceutical was listed in Shenzhen Stock Exchange (stock code: 300436), becoming the first company in Ningde, Fujian listed in the said exchange. By Nov. 11,2015, the market value of Cosunter has reached about 15.1 billion yuan.